What is Paxlovid Rebound?
Paxlovid rebounding is defined as the return of covid-19 symptoms and/or new positive COVID-19 test after having tested negative and completing the paxlovid treatment. This phenomenon has been seen in both unvaccinated and vaccinated individuals.
Mask and Vaccine Mandates in the 50 U.S. States.
As of February 17, 2022, only four U.S. states (Hawaii, Illinois, Oregon, and Washington) continue to have indoor mask mandates. Other states have switched to requiring masks only for unvaccinated individuals and in public spaces. The remaining eleven states have not imposed any mask mandates to date. As for a vaccine mandate, 46% of the states require their residents to get vaccinated for COVID-19, while 30% have no active mandate in place.
Does the COVID-19 Vaccine Protect Against the Omicron Variant?
The currently available COVID-19 vaccines protect against severe illness, hospitalizations, and deaths due to the Omicron variant. Breakthrough infections in people who are fully vaccinated may occur, but most vaccinated individuals have reported mild or no symptoms from the Omicron variant.
Are At-Home COVID-19 Tests Covered By Insurance?
With new variants emerging, at-home COVID-19 tests are becoming more widespread within various drug stores. However, their costs have remained an issue for many Americans. In general, health insurance companies do not cover the cost of an at-home COVID-19 test.
Are At-Home COVID-19 Tests Accurate?
At-home COVID-19 tests, called rapid antigen tests, are a quick, convenient way to test yourself for COVID-19. However, these tests are not perfect. At-home COVID-19 tests detect about 85% of positive cases on average.
What Are the Symptoms of the Omicron COVID-19 Variant?
The symptoms of the Omicron COVID-19 variant are similar to other COVID-19 variants: fever, cough, shortness of breath, and muscle aches; however, there are fewer reports of significant loss of taste and smell with the Omicron variant.
Lambda and Delta Plus: What To Know About COVID-19 Variants
In recent news, a John Hopkins University COVID researcher described the Lambda variant as a “potential threat to human society”, and there has been widespread concern about the efficacy of vaccines against the Delta and Delta Plus variant. What do we know about these COVID-19 variants thus far?